↓ Skip to main content

Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting

Overview of attention for article published in Journal of Hematology & Oncology, March 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting
Published in
Journal of Hematology & Oncology, March 2023
DOI 10.1186/s13045-023-01411-x
Pubmed ID
Authors

Katherine W. DiNardo, Thomas W. LeBlanc, Hui Chen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 19%
Unspecified 2 13%
Student > Bachelor 2 13%
Student > Doctoral Student 1 6%
Student > Master 1 6%
Other 2 13%
Unknown 5 31%
Readers by discipline Count As %
Medicine and Dentistry 4 25%
Unspecified 2 13%
Biochemistry, Genetics and Molecular Biology 2 13%
Nursing and Health Professions 1 6%
Chemistry 1 6%
Other 1 6%
Unknown 5 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2023.
All research outputs
#3,245,205
of 23,505,669 outputs
Outputs from Journal of Hematology & Oncology
#249
of 1,216 outputs
Outputs of similar age
#50,729
of 360,120 outputs
Outputs of similar age from Journal of Hematology & Oncology
#3
of 24 outputs
Altmetric has tracked 23,505,669 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,216 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,120 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.